Today’s Research Reports on Trending Tickers: Horizon Pharma and Ironwood Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / May 10, 2018 / U.S. markets spiked Wednesday as strong performances by the energy, financials and technology sectors lifted the major indexes higher. The Dow Jones Industrial Average jumped 0.75 percent to close at 24,542.54, while the S&P 500 Index spiked 0.97 percent to close at 2,697.79. The Nasdaq Composite Index rose 1.00 percent to close at 7,339.91. Energy stocks continued to rise a day after President Trump’s decision to pull out of the nuclear deal with Iran and to continue with sanctions against the major oil producing nation.

“A lot of people had reduced their exposure to stocks ahead of Trump’s announcement on Iran on Tuesday and when the markets did not sell off, traders went back in. What we are seeing today looks like a relief rally that took the S&P 500 to the high end of its recent range,” said Ian Winer, head of the equities division at Wedbush Securities, according to MarketWatch.

RDI Initiates Coverage on:

Horizon Pharma PLC
https://rdinvesting.com/news/?ticker=HZNP

Ironwood Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=IRWD

Horizon Pharma’s stock moved 5.6% lower Wednesday, to close the day at $13.81. The stock recorded a trading volume of 5,556,714 shares, which was above its three months average volume of 1,823,849 shares. In the last year, Horizon Pharma’s shares have traded in a range of 9.45 – 16.02. The share price has gained 46.14% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $13.94 is below its 200-day moving average of $14.37. Shares of Horizon Pharma have gained roughly 1.25 percent in the past month and are down 5.41 percent year-to-date.

Access RDI’s Horizon Pharma PLC Research Report at:
https://rdinvesting.com/news/?ticker=HZNP

On Wednesday, shares of Ironwood Pharmaceuticals recorded a trading volume of 1,491,757 shares, which was above the three months average volume of 1,419,509 shares. The stock ended the day 4.52% lower at $17.55. The share price has fallen 11.99% from its 52 week high with a 52 week trading range of 12.89 – 19.94. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $16.63 is above its 200-day moving average of $15.52. Shares of Ironwood Pharmaceuticals have gained roughly 10.59 percent in the past month and are up 17.08 percent year-to-date.

Access RDI’s Ironwood Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IRWD

Our Actionable Research on Horizon Pharma Public Limited Company (NASDAQ :HZNP) and Ironwood Pharmaceuticals, Inc. (NASDAQ :IRWD) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 499245